- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Fineotex Chemical has announced a board meeting where it approved the financial results for the quarter ended June 30, 2025. Consolidated revenue rose 14.43% to ₹137.07 Cr, with PAT up 24.34% to ₹25.03 Cr. Operational EBITDA grew 18.37% to ₹25.20 Cr, reflecting strong performance and 14.73% volume growth. A significant operational update is the commissioning of a new 300,000 sq. ft. manufacturing facility at Ambernath, enhancing capacity. The board also approved the appointment of Mr. Chetan Shah as an Independent Director and M/s. HSPN & Associates as Secretarial Auditor, subject to AGM approval. The 22nd Annual General Meeting will be held on September 19, 2025.